ROCKET PHARMACEUTICALS, INC.·4

Nov 10, 4:25 PM ET

Wilson Martin 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-03
Wilson Martin
General Counsel
Transactions
  • Award

    Common Stock

    2025-11-03+100,000385,462 total
Footnotes (2)
  • [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  • [F2]Represent RSUs that convert to common stock on a one-for-one basis. The RSUs will become fully vested on November 3, 2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4